Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity

BACKGROUND: Human recombinant erythropoietin (rHuEpo) that is used for the treatment of the chemotherapy-induced anaemia in cancer patients was shown to cause detrimental effects on the course of disease due to increased adverse events inflicting patient’s survival, potentially related to rHuEpo-ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Trost, Nina, Juvan, Peter, Sersa, Gregor, Debeljak, Natasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472952/
https://www.ncbi.nlm.nih.gov/pubmed/23077460
http://dx.doi.org/10.2478/v10019-012-0037-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472952/
https://www.ncbi.nlm.nih.gov/pubmed/23077460
http://dx.doi.org/10.2478/v10019-012-0037-8

Ejemplares similares